Aurobindo acquires Apotex Inc's biz in 5 European countries for 74 mn euros

The acquisition includes a portfolio of over 200 prescription drugs and 88 OTC products and an additional pipeline of over 20 products.

Hyderabad's Aurobindo Pharma has signed a definitive agreement to acquire Canadian pharmaceuticals company Apotex International Inc's commercial operations and certain supporting infrastructure in five European countries for €74 million (Rs 5.93 bn) in an all-cash deal. 

The acquisition will extend and diversify Aurobindo’s European product portfolio by adding over 200 generics and more than 80 over-the-counter products that had total sales of 133 million euros in the year ending March 2018. Aurobindo clocked a sales of €577 million in Europe last fiscal. The Hyderabad-based company, in fact, led the pack amongst Indian pharma majors with a 33 per cent year-on-year